Status:
COMPLETED
Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
Lead Sponsor:
CoAxia
Conditions:
Cerebrovascular Accident
Eligibility:
All Genders
18-85 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the safety and feasibility of the NeuroFlo™ catheter in treating patients with ischemic stroke whose last time symptom-free was between 8-24 hours prior to treat...
Detailed Description
The study is a prospective, single arm treatment feasibility trial to determine the baseline safety and feasibility of the NeuroFlo device in acute ischemic stroke patients whose last known time sympt...
Eligibility Criteria
Inclusion
- Ischemic stroke
- NIHSS between 4-20
- Time from symptom onset between 8 and 24 hours
Exclusion
- Hemorrhagic stroke
- Certain types of heart disease
- Kidney disease
- Other conditions the doctor will assess
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00436592
Start Date
February 1 2007
End Date
January 1 2009
Last Update
February 5 2009
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90024
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
3
University of Rochester
Rochester, New York, United States, 14642
4
University of North Carolina
Chapel Hill, North Carolina, United States, 27514